SCA Pharma Awarded Multi-Year Contract with Vizient, Supporting Better Drug Accessibility
Windsor, CT, November 1, 2022– SCA Pharma, a nationally recognized leader in the 503B compounded pharmaceuticals outsourcing industry, providing quality, service, and value to hospitals nationwide, has announced today that Vizient has awarded a multi-year agreement to the company for its full range of 503B ready-to-use products. Vizient is one of the nation’s leading health…